Search

Your search keyword '"Morris, Huw R"' showing total 870 results

Search Constraints

Start Over You searched for: Author "Morris, Huw R" Remove constraint Author: "Morris, Huw R"
870 results on '"Morris, Huw R"'

Search Results

1. Investigation of the genetic aetiology of Lewy body diseases with and without dementia

2. Parkinson’s families project: a UK-wide study of early onset and familial Parkinson’s disease

3. Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genes

4. Genome-wide determinants of mortality and motor progression in Parkinson’s disease

5. Genotype–phenotype correlation in PRKN-associated Parkinson’s disease

6. Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias

7. Uncovering spatiotemporal patterns of atrophy in progressive supranuclear palsy using unsupervised machine learning.

8. Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups.

9. Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia

10. RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses

11. Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)

13. Current directions in tau research: Highlights from Tau 2020

14. MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study

15. Current directions in tau research: Highlights from Tau 2020.

17. Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial.

18. Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study

19. Author Correction: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial

20. Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias

21. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies

22. Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood

25. How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy.

28. The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease

29. Multi-modality machine learning predicting Parkinson’s disease

30. Assessing cognitive dysfunction in Parkinson's disease: An online tool to detect visuo‐perceptual deficits

31. MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study

32. α‐Synuclein Pathology in PRKN‐Linked Parkinson's Disease: New Insights from a Blood‐Based Seed Amplification Assay

33. The role of dopaminergic medication, lipid, and endocannabinoid pathway alterations in idiopathic andPRKN/PINK1-mediated Parkinson’s disease – a large-scale targeted metabolomics study

37. Genome-wide Pleiotropy Between Parkinson Disease and Autoimmune Diseases.

38. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.

39. Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study

40. Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture

42. Frequency and outcomes of gastrostomy insertion in a longitudinal cohort study of atypical parkinsonism.

43. Motor Complications in Parkinson's Disease: Results from 3343 Patients Followed for up to 12 Years.

44. Loss-of-function SMPD1 gene variant in Progressive Supranuclear Palsy-Richardson Syndrome patients of Chinese ancestry

45. A pathogenic variant in RAB32 causes autosomal dominant Parkinsons disease and activates LRRK2 kinase

46. A Pathogenic Variant in Rab32 Causes Autosomal Dominant Parkinson's Disease and Activates LRRK2 Kinase

47. A genome-wide association study in multiple system atrophy

48. Parkinson’s Families Project: a UK-wide study of early onset and familial Parkinson’s disease

49. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies

50. Fulminant corticobasal degeneration: a distinct variant with predominant neuronal tau aggregates

Catalog

Books, media, physical & digital resources